2016. Diabetes Australia. Determining the cellular mechanisms of insulin resistance in obese women who develop gestational diabetes: Placenta-derived exosome, a possible biomarker for the early detection of gestational diabetes.
2017. Bill & Melissa Gates Foundation. Profiling of Placental Physiologic Signature During Pregnancy in Maternal Liquid Biopsies.
2016-2017. UQ-Ochsner Seed Fund. Placenta-derived exosomes, a possible biomarker for early detection of preeclampsia.
2016-2017. UQ-Ochsner Seed Fund for Collaborative Research, Ochsner Medical Center and University of Queensland. ‘MicroRNA and proteomic signatures of tumour-derived exosomes as early diagnostic tool of ovarian cancer progression’.
2015-2016. Exosomes as potential biomarkers for pancreatic cyst risk stratification for Pancreatic cancer. Funding source: 2015 Academic Title Holder Research Fund Scheme.
2015-2018. Tumor-derived exosomes and ovarian cancer. Funding source: generic donation.
2016-2019. NHMRC development grant (APP1114013). In vitro diagnostic for first trimester risk assignment of gestational diabetes.
2016 M+BS Emerging Leaders Medical Research Grant, titled Identification of exosomal miRNA targets involved in drug resistance in ovarian cancer.
2016 Brisbane Diamantina Health Partners (BDHP) Strategic Initiative Grant Scheme. The Queensland Gynaecological Cancer Initiative.
2016 UQ FirstLink Scheme. Large scale production and purification of placental exosomes with clinical Good Manufacturing Practice (GMP)-grade for biomarker applications.
